We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00111449
First Posted: May 23, 2005
Last Update Posted: May 15, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by (Responsible Party):
Amgen